Loading interface...

Monlevo-A Tablet

Manufactured byAcinom Healthcare
ContainsAmbroxol (60 mg) + Levocetirizine (5 mg)
Description
Monlevo-A Tablet is a combination of Ambroxol and Levocetirizine. It is used to treat cough and allergic symptoms such as sneezing, runny nose, watery eyes, etc. It works by blocking the action of a chemical substance responsible for allergy. It also helps to loosen the thick mucous and makes it easier to cough out. Monlevo-A Tablet may cause some common side effects such as sleepiness, diarrhoea, dry mouth, tirednes, headache, etc. Consult your doctor if these symptoms stay for a long time or if they become severe. Monlevo-A Tablet should be taken as prescribed by your doctor. Avoid taking more or less than the prescribed dose. Avoid the discontinuation of this medicine without consulting your doctor. Consult your doctor if your symptoms do not improve even after taking this medicine for the prescribed duration. Monlevo-A Tablet should be avoided if you are allergic to it. Inform your doctor if you have liver or kidney problems. This medicine is not recommended for use in children below 12 years of age. Consult your doctor if you are pregnant, or are breastfeeding.

Side effects

Major & minor side effects for Monlevo-A Tablet

  • Nausea and Vomiting
  • Diarrhoea
  • Headache
  • Sleepiness
  • Tiredness
  • Dry mouth
  • Dizziness
  • Stomach pain

Uses of Monlevo-A Tablet

What is it prescribed for?

  • Productive cough
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Monlevo-A Tablet can be observed within 30 minutes of administration.
  • How long do the effects of this medicine last?
    The average time for which Monlevo-A Tablet acts in your body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with Monlevo-A Tablet as it may increase the risk of side effects such as dizziness, drowsiness, and difficulty in concentration.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported with Monlevo-A Tablet.
  • Can this medicine be taken during pregnancy?
    Monlevo-A Tablet is not recommended during pregnancy due to lack of sufficient safety data. Hence, consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Monlevo-A Tablet is not recommended while breastfeeding as it may pass into breastmilk. Hence, consult your doctor if you are breastfeeding.

Severe kidney impairment

Monlevo-A Tablet is not recommended for use if you have severe kidney problems. This medicine is excreted from your body through kidneys and impaired kidney function may lead to an increased risk of side effects.

Allergy

Avoid taking Monlevo-A Tablet if you are allergic to it. Seek immediate medical attention if you notice any worsening of your allergic symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Monlevo-A Tablet is not recommended during pregnancy due to lack of sufficient safety data. Hence, consult your doctor if you are pregnant.

Breast-feeding

Monlevo-A Tablet is not recommended while breastfeeding as it may pass into breastmilk. Hence, consult your doctor if you are breastfeeding.
General warnings

Driving or operating machines

Monlevo-A Tablet may cause dizziness or drowsiness. If you experience such symptoms, avoid performing activities that require high mental alertness like driving vehicles or operating machines.

Use in children

Monlevo-A Tablet is not recommended for use in children below 12 years of age due to a lack of relevant safety and efficacy data.

Other medicines

Monlevo-A Tablet may increase the risk of side effects like sleepiness and impaired ability to think when taken with other medicines like sedatives (sleep-inducing medicine). Hence, inform your doctor about all your current medicines including any herbs or supplements before beginning the treatment with this medicine.

Urinary retention

Urinary retention is a condition in which you are unable to empty your bladder completely during urination. It may occur due to various conditions like benign prostatic hyperplasia (a condition that causes abnormal enlargement of prostate glands), spinal cord lesion [damaged tissue of the spine (backbone)], etc. Monlevo-A Tablet should be used with caution if you have such conditions as it may increase the risk of urinary retention.

Missed Dose

Try not to skip a dose of Monlevo-A Tablet. Take the missed dose as soon as you remember. If it is time for your next dose, skip the missed one. Do not double the dose to make up for a missed one.

Overdose

Do not take more than the prescribed dose. Reach the nearest emergency medical department in case of an overdose with Monlevo-A Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Monlevo-A Tablet as it may increase the risk of side effects such as dizziness, drowsiness, and difficulty in concentration.
Interaction with Medicine

Alprazolam

Tramadol

Codeine

Gabapentin

Zolpidem

Lorazepam

Pregabalin

Disease interactions

Gastric ulceration

Monlevo-A Tablet should be used with caution if you have an active or a history of gastric ulcers (sores in the lining of the stomach and intestine). This medicine may further damage the lining of your stomach and intestine and worsen your condition. Consult your doctor before taking this medicine.

Kidney impairment

Monlevo-A Tablet should be used with caution if you have kidney problems. Impaired kidney function may lead to the accumulation of this medicine in your body and increase the risk of side effects. Your doctor may suggest another suitable medicine or adjust the dose accordingly based on your condition.

Liver impairment

Monlevo-A Tablet should be used with caution if you have liver problems as this medicine is broken down in your liver. Hence, impaired liver function may increase the risk of side effects. Your doctor may suggest tests to monitor your liver function while you are taking this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Monlevo-A Tablet with or without food as directed by your doctor. Do not break, crush, or chew the tablet. Drink an adequate amount of water as it can also help in loosening mucous from your airways. Avoid taking more or less than the prescribed dose. Avoid discontinuation of Monlevo-A Tablet without consulting your doctor. Avoid consuming alcohol while taking Monlevo-A Tablet as it may cause severe drowsiness and dizziness. Do not drive or operate machines after taking this medicine as it may affect your alertness.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
Monlevo-A Tablet is a combination of Ambroxol and Levocetirizine. Ambroxol works by loosening the mucous making it easier to cough out. Levocetirizine works by blocking the action of histamine, a chemical responsible for allergy. Thus, it provides relief from allergic symptoms.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Mucolytics, Antihistamines

Schedule

Schedule H

Pubchem.ncbi.nlm.nih.gov. 2021. Ambroxol. [online] Available at: < [Accessed 18 August 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Ambroxol>

Dailymed.nlm.nih.gov. 2021. DailyMed - LEVOCETIRIZINE DIHYDROCHLORIDE tablet. [online] Available at: < [Accessed 2 September 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d416349-161d-4232-b6b4-e75214ea4841>

Drugs, H., 2021. Levocetirizine: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 2 September 2021].

https://medlineplus.gov/druginfo/meds/a607056.html>

Medicines.org.uk. 2021. Levocetirizine 5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 2 September 2021].

https://www.medicines.org.uk/emc/product/9917/smpc#gref>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 2 September 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022064s009lbl.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 23 Sep 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.